Investment Analysts’ Updated EPS Estimates for September 13th (ADBE, ALGN, ANET, AURA, AVNW, CNO, COP, CTMX, CXW, EBS)

Investment Analysts’ updated eps estimates for Friday, September 13th:

Adobe (NASDAQ:ADBE) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $635.00 target price on the stock.

Adobe (NASDAQ:ADBE) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $610.00 target price on the stock.

Adobe (NASDAQ:ADBE) had its overweight rating reaffirmed by analysts at Morgan Stanley. They currently have a $660.00 price target on the stock.

Adobe (NASDAQ:ADBE) had its market perform rating reaffirmed by analysts at JMP Securities.

Adobe (NASDAQ:ADBE) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. The firm currently has a $625.00 price target on the stock.

Adobe (NASDAQ:ADBE) had its buy rating reissued by analysts at Bank of America Co.. The firm currently has a $640.00 price target on the stock.

Align Technology (NASDAQ:ALGN) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $315.00 price target on the stock.

Arista Networks (NYSE:ANET) had its outperform rating reiterated by analysts at Evercore ISI. The firm currently has a $400.00 price target on the stock.

Aura Biosciences (NASDAQ:AURA) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $21.00 target price on the stock.

Aviat Networks (NASDAQ:AVNW) had its outperform rating reissued by analysts at Northland Securities. They currently have a $40.00 target price on the stock, down from their previous target price of $50.00.

CNO Financial Group (NYSE:CNO) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $37.00 target price on the stock.

ConocoPhillips (NYSE:COP) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $140.00 price target on the stock.

CytomX Therapeutics (NASDAQ:CTMX) had its neutral rating reiterated by analysts at HC Wainwright.

CoreCivic (NYSE:CXW) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $14.00 target price on the stock.

Emergent BioSolutions (NYSE:EBS) had its buy rating reiterated by analysts at Rodman & Renshaw. They currently have a $16.00 price target on the stock.

Evolus (NASDAQ:EOLS) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $22.00 price target on the stock.

EQT (NYSE:EQT) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $45.00 target price on the stock.

FedEx (NYSE:FDX) had its outperform rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $340.00 price target on the stock.

Gevo (NASDAQ:GEVO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $14.00 target price on the stock.

Genmab A/S (NASDAQ:GMAB) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $50.00 target price on the stock.

Halozyme Therapeutics (NASDAQ:HALO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $65.00 price target on the stock.

Immuneering (NASDAQ:IMRX) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $15.00 price target on the stock.

Indivior (NASDAQ:INDV) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $22.00 target price on the stock.

Innate Pharma (NASDAQ:IPHA) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $11.50 price target on the stock.

OrthoPediatrics (NASDAQ:KIDS) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $42.00 target price on the stock.

OrthoPediatrics (NASDAQ:KIDS) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $50.00 price target on the stock.

OrthoPediatrics (NASDAQ:KIDS) had its hold rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $34.00 target price on the stock, up from their previous target price of $30.00.

Kratos Defense & Security Solutions (NASDAQ:KTOS) had its buy rating reiterated by analysts at Benchmark Co.. Benchmark Co. currently has a $25.00 price target on the stock.

LegalZoom.com (NASDAQ:LZ) had its market perform rating reissued by analysts at JMP Securities.

Manitex International (NASDAQ:MNTX) had its market perform rating reaffirmed by analysts at Northland Securities. The firm currently has a $5.80 price target on the stock, down from their previous price target of $8.00.

Moderna (NASDAQ:MRNA) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Morgan Stanley Direct Lending (NYSE:MSDL) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $22.00 target price on the stock.

Morgan Stanley Direct Lending (NYSE:MSDL) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $22.00 price target on the stock.

Natera (NASDAQ:NTRA) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $150.00 price target on the stock.

Phathom Pharmaceuticals (NASDAQ:PHAT) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $26.00 target price on the stock.

Pinterest (NYSE:PINS) had its overweight rating reiterated by analysts at Piper Sandler. They currently have a $45.00 price target on the stock.

Pliant Therapeutics (NASDAQ:PLRX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $38.00 target price on the stock.

Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $45.00 price target on the stock.

Roku (NASDAQ:ROKU) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $100.00 target price on the stock.

RxSight (NASDAQ:RXST) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $66.00 target price on the stock.

SentinelOne (NYSE:S) had its neutral rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They currently have a $25.00 price target on the stock.

Tenable (NASDAQ:TENB) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $50.00 target price on the stock.

Tyler Technologies (NYSE:TYL) had its buy rating reiterated by analysts at The Goldman Sachs Group, Inc.. They currently have a $627.00 price target on the stock.

Unity Software (NYSE:U) had its market perform rating reaffirmed by analysts at JMP Securities.

Uber Technologies (NYSE:UBER) had its overweight rating reiterated by analysts at Wells Fargo & Company. The firm currently has a $97.00 price target on the stock.

Upbound Group (NASDAQ:UPBD) had its hold rating reissued by analysts at Loop Capital. Loop Capital currently has a $36.00 target price on the stock.

U.S. Bancorp (NYSE:USB) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $48.00 price target on the stock.

Warner Bros. Discovery (NASDAQ:WBD) had its neutral rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $9.00 target price on the stock.

Warner Bros. Discovery (NASDAQ:WBD) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $18.00 target price on the stock.

Zimmer Biomet (NYSE:ZBH) had its hold rating reaffirmed by analysts at Truist Financial Co.. They currently have a $112.00 target price on the stock, down from their previous target price of $117.00.